Impurities in Drug Products and Active Pharmaceutical Ingredients

References

• Bauer, M.; Möller, H. J.; Schneider, E. Duloxetine: A New Selective and Dual-acting Antidepressant. Expert Opin. Pharmacother. 2006, 7, 421–427.
   PubMed Web of Science ®Google Scholar
• Bundgaard, H.; De Weck, A. L. The Role of Amino-Reactive Impurities in Acetylsalicylic Acid Allergy. Int. Arch. Allergy Immunol. 1975, 49, 119–124.
   Web of Science ®Google Scholar
• Chhalotiya, U. K.; Bhatt, K. K.; Shah, D. A.; Baldania, S. L. Development and Validation of a Stability-Indicating RP-HPLC Method for Duloxetine Hydrochloride in its Bulk and Tablet Dosage form. Scientia Pharmaceutica 2010, 78, 857–868.
   PubMedGoogle Scholar
• Clegg, S.; Safe, S.; Crocker, J. F. S. Identification of a Toxic Impurity in Commercial Diphenylamine. J. Environ. Sci. Health, Part B. 1981, 16, 125–130.
   PubMed Web of Science ®Google Scholar
• Drug definition US FDA Drug Approval Process. Pharmacist Pharma J. 2010 http://www.pharmacistspharmajournal.org/2010/2011/definitions-of-drug-radioactive-drug_2011.html#.V2011SecNmLTIV.
   Google Scholar
• Elshanawane, A. A.; Abdelaziz, L. M.; Kamal, M. M.; Hafez, H. M. Quantitative Determination of Telmisartan, Ramipril, Amlodipine Besylate, and Atorvastatin Calcium by HPLC. J. Liquid Chromatogr. Related Technol. 2013, 37, 195–206.
   Web of Science ®Google Scholar
• Ertürk, S.; Aktaş, E. S.; Ersoy, L.; Fiçicioǧlu, S. An HPLC Method for the Determination of Atorvastatin and its Impurities in Bulk Drug and Tablets. J. Pharmaceutical Biomed. Anal. 2003, 33, 1017–1023.
   PubMed Web of Science ®Google Scholar
• Gupta, L. K. Spectroscopic Characterization and Quantitative Determination of Atorvastatin Calcium Impurities by Novel HPLC Method. Spectrochim. Acta - Part A: Molecular Biomolecular Spectrosc. 2012, 97, 495–501.
   PubMed Web of Science ®Google Scholar
• Husain, S.; Nageswara Rao, R. Monitoring of Process Impurities in Drugs, Advanced Chromatographic and Electromigration Methods in Biosciences; Elsevier Science: Amsterdam, 1998, 834–888.
   Google Scholar
• ICH. Impurities in new drug substances Q3A (R2), International Conference on Harmonization, Geneva, Switzerland, IFPMA, 2006.
   Google Scholar
• IMS Top 20 Global Products, IMS Health MIDAS, DOI (2011) http://www.imshealth.com/files/web/Corporate/News/TopLine%20Market%20Data/Top_20_Global_Products.pdf.
   Google Scholar
• IMS Top 20 Global Products, IMS Health MIDAS, DOI (2012) http://www.imshealth.com/files/web/Corporate/News/TopLine%20Market%20Data/2012/Top_2020_Global_Products_2012_2012.pdf.
   Google Scholar
• IMS Top 20 Global Products, IMS Health MIDAS, DOI (2013) http://www.imshealth.com/files/web/Corporate/News/TopLine%20Market%20Data/Global%20Prescription%20Sales%20Information21Top_20_Global_Products_2013.pdf.
   Google Scholar
• Jain, D.; Basniwal, P. K. Forced Degradation and Impurity Profiling: Recent Trends in Analytical Perspectives. J. Pharmaceutical Biomed. Anal. 2013, 86, 11–35.
   PubMed Web of Science ®Google Scholar
• Karagiannidou, E. G.; Bekiari, E. T.; Vastardi, E. I. A Validated RP-HPLC Method for the Analysis of 1-fluoronaphthalene and its Process-Related Impurities. J. Chromatogr. Sci. 2015, 53, 1296–1302.
   PubMed Web of Science ®Google Scholar
• Kowalski, A.; Frankowski, M. Levels and Potential Health Risks of Mercury in Prescription, Non-Prescription Medicines and Dietary Supplements in Poland. Regulatory Toxicol. Pharmacol. 2015, 73, 396–400.
   PubMed Web of Science ®Google Scholar
• Kumar, N.; Sangeetha, D.; Vaghela, B.; Reddy, P. S.; Raghav, A. Development and Validation of a Stability Indicating RP-LC Method for the Estimation of Process Related Impurities and Degradation Products of Duloxetine Hydrochloride and Phthalic Acid in Duloxetine Hydrochloride Delayed Release Capsules. J. Liquid Chromatogr. Related Technol. 2012, 35, 867–881.
   Web of Science ®Google Scholar
• Londhe, S. V.; Deshmukh, R. S.; Mulgund, S. V.; Jain, K. S. Development and Validation of a Reversed-phase HPLC Method for Simultaneous Determination of Aspirin, Atorvastatin Calcium and Clopidogrel Bisulphate in Capsules. Indian J. Pharmaceutical Sci. 2011, 73, 23–29.
   PubMed Web of Science ®Google Scholar
• Maggio, R. M.; Calvo, N. L.; Vignaduzzo, S. E.; Kaufman, T. S. Pharmaceutical Impurities and Degradation Products: Uses and Applications of NMR techniques. J. Pharmaceutical Biomed. Anal. 2014, 101, 102–122.
   PubMed Web of Science ®Google Scholar
• Matveeva, O. A.; Kovaleva, E. L. Modern Approaches to Estimating the Content of Genotoxic Impurities in Drugs (a Review). Pharmaceutical Chem. J. 2016, 49, 765–770.
   Web of Science ®Google Scholar
• Mercolini, L.; Mandrioli, R.; Cazzolla, R.; Amore, M.; Raggi, M. A. HPLC Analysis of the Novel Antidepressant Duloxetine in Human Plasma After an Original Solid-phase Extraction Procedure. J. Chromatogr. B: Analytical Technol. Biomed. Life Sci. 2007, 856, 81–87.
   PubMed Web of Science ®Google Scholar
• Mohammadi, A.; Rezanour, N.; Ansari Dogaheh, M.; Ghorbani Bidkorbeh, F.; Hashem, M.; Walker, R. B. A Stability-Indicating High Performance Liquid Chromatographic (HPLC) Assay for the Simultaneous Determination of Atorvastatin and Amlodipine in Commercial Tablets. J. Chromatogr. B: Analytical Technol. Biomed. Life Sci. 2007, 846, 215–221.
   PubMed Web of Science ®Google Scholar
• Nageswara Rao, R.; Nagaraju, V. An Overview of the Recent Trends in Development of HPLC Methods for Determination of Impurities in Drugs. J. Pharmaceutical Biomed. Anal. 2003, 33, 335–377.
   PubMed Web of Science ®Google Scholar
• Nováková, L.; Šatínský, D.; Solich, P. HPLC Methods for the Determination of Simvastatin and Atorvastatin. TrAC - Trends in Analytical Chem. 2008, 27, 352–367.
   Web of Science ®Google Scholar
• Patil, P. P.; Kasture, V.S.; Prakash, K. V. Impurity Profiling Emerging Trends in Quality Control of Pharmaceuticals. Int. J. Pharmaceutical Chem. 2015, 5, 1–10.
   Google Scholar
• Puranik, M.; Wadher, S.; Sharma, K. A Simple, Novel Validated Stability Indicating RP-HPLC Method for Estimation of Duloxetine HCL in Capsule Pharmaceutical Formulation. Indian J. Pharmaceutical Education Res. 2014, 48, 91–98.
   Web of Science ®Google Scholar
• Qiu, F.; Norwood, D. L. Identification of Pharmaceutical Impurities. J. Liquid Chromatogr. Related Technol. 2007, 30, 877–935.
   Web of Science ®Google Scholar
• Raman, N. V.; Harikrishna, K. A.; Prasad, A. V.; Reddy, K. R.; Ramakrishna, K. Determination of Duloxetine Hydrochloride in the Presence of Process and Degradation Impurities by a Validated Stability-Indicating RP-LC Method. J. Pharmaceutical Biomed. Anal. 2010, 51, 994–997.
   PubMed Web of Science ®Google Scholar
• Ramesha, B.; Reddy, K. R. V.; Kishore, B. V.; Kumar Amith, M. K.; Raju, L. P.; Thara, B. N. Development and Validation of a Stability-Indicating Gradient RP-UHPLC Method for the Determination of Impurities in Atorvastatin Drug Substance. J. Liquid Chromatogr. Related Technol. 2014, 37, 275–297.
   Web of Science ®Google Scholar
• Rao, D. D.; Sait, S. S.; Reddy, A. M.; Chakole, D.; Reddy, Y. R.; Mukkanti, K. Analysis of Duloxetine Hydrochloride and its Related Compounds in Pharmaceutical Dosage forms and in Vitro Dissolution Studies by Stability Indicating UPLC. J. Chromatogr. Sci. 2010, 48, 819–824.
   PubMed Web of Science ®Google Scholar
• Reddy, P. R. M.; Sreeramulu, J.; Naidu, P. Y.; Reddy, A. R. Stability Indicating fast LC for the Simultaneous Estimation of Intermediates and Degradants of Duloxetine Hydrochloride. Chromatographia. 2010, 71, 95–100.
   Web of Science ®Google Scholar
• Reddy, A. V.; Sreenivas Ulareddy, B. M.; Kameshwar Rao, K. R.; Madhusudhanreddy, B. Stability Indicating Nature of RP-HPLC Method for Determination of Impurity Profile and Degradation Impurities in Duloxetine Hydrochloride. Der. Pharma Chemica. 2012, 4, 1735–1741.
   Google Scholar
• Sangshetti, J. N.; Aqeel, M.; Zaheer, Z.; Ahmed, R. Z.; Dehghan, M. H. G.; Gonjari, I. Development and Validation of RP-HPLC Method for Determination of Atorvastatin Calcium and Nicotinic Acid in Combined Tablet Dosage form. J. Saudi Chem. Soc. 2012.
   Google Scholar
• Shah, D. A.; Bhatt, K. K.; Mehta, R. S.; Baldania, S. L.; Gandhi, T. R. Stability Indicating RP-HPLC Estimation of Atorvastatin Calcium and Amlodipine Besylate in Pharmaceutical Formulations. Indian J. Pharmaceutical Sci. 2008, 70, 754–760.
   PubMed Web of Science ®Google Scholar
• Soni, P.; Mariappan, T. T.; Banerjee, U. C. High-Performance Liquid Chromatographic Method for the Simultaneous Estimation of the key Intermediates of Duloxetine. Talanta. 2005, 67, 975–978.
   PubMed Web of Science ®Google Scholar
• Srinivasulu, P.; Srinivas, K. S.; Reddy, R. S.; Mukkanti, K.; Buchireddy, R. A Validated Stability Indicating Rapid LC Method for Duloxetine HCl. Pharmazie. 2009, 64, 10–13.
   PubMed Web of Science ®Google Scholar
• Stach, J.; Havlíček, J.; Plaček, L.; Rádl, S. Synthesis of Some Impurities and/or Degradation Products of Atorvastatin. Collection of Czechoslovak Chem. Commun. 2008, 73, 229–246.
   Google Scholar
• Vadlamudi, M. K.; Dhanaraj, S.; Yarkala, S.; Jayapal, J. J.; Kommavarapu, P. K. Development of Stability Indicating RP-HPLC Method for the Determination of Related Substances in Atorvastatin Solid Dosage form and Bulk Drugs. Int. J. Pharmacy Pharmaceutical Sci. 2015, 7, 184–194.
   Google Scholar
• Vora, D. N.; Kadav, A. A. Validated Ultra HPLC Method for the Simultaneous Determination of Atorvastatin, Aspirin, and Their Degradation Products in Capsules. J. Liquid Chromatogr. Related Technol. 2008, 31, 2821–2837.
   Web of Science ®Google Scholar
• Vukkum, P.; Moses Babu, J.; Muralikrishna, R. Stress Degradation Behavior of Atorvastatin Calcium and Development of a Suitable Stability-Indicating LC Method for the Determination of Atorvastatin, its Related Impurities, and its Degradation Products. Scientia Pharmaceutica. 2013, 81, 93–114.
   PubMedGoogle Scholar